Universe Pharmaceuticals INC Gross Profit

Universe Pharmaceuticals INC (UPC) currently reports a gross profit of $12M as of March 2026. That compares with $21M in the prior-year period — down 42.2% year over year. That is below the Healthcare sector average of $66B. Use the charts on this page to explore Universe Pharmaceuticals INC's gross profit history and peer comparisons.

Universe Pharmaceuticals INC's gross profit decreased from $21M to $12M — a 42.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Universe Pharmaceuticals INC's gross profit of $12M is lower than the Healthcare sector average of $66B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Universe Pharmaceuticals INC reported $12M in gross profit as of March 2026. That compares with $21M in the prior-year period — down 42.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $66B. From there, open related valuation or income-statement pages for Universe Pharmaceuticals INC, and consider following UPC for alerts when major investors trade the stock.